We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
-20.19%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$87.9M
AUM Growth
-$30.4M
Cap. Flow
-$1.99M
Cap. Flow %
-2.26%
Top 10 Hldgs %
97.63%
Holding
18
New
1
Increased
–
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
MTEM
Molecular Templates, Inc.
MTEM
+$530K

Top Sells

Rank Stock Value
1
NTBL
Notable Labs, Ltd. Ordinary Shares
NTBL
+$1.49M
2
VNRX icon
VolitionRx Ltd
VNRX
+$916K
3
OTRK
Ontrak
OTRK
+$102K
4
NAGE
Niagen Bioscience
NAGE
+$9.89K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$27.7M 31.54%
749,815
– –
CRBP icon
2
Corbus Pharmaceuticals
CRBP
$170M
$23.7M 26.99%
135,426
– –
ABEO icon
3
Abeona Therapeutics
ABEO
$345M
$16.8M 19.17%
94,391
– –
KRYS icon
4
Krystal Biotech
KRYS
$9.88B
$6.23M 7.09%
300,000
– –
ALDX icon
5
Aldeyra Therapeutics
ALDX
$91.7M
$4.02M 4.57%
484,096
– –
ECOR icon
6
electroCore
ECOR
$51.4M
$2.48M 2.83%
26,481
– –
ENTX icon
7
Entera Bio
ENTX
$101M
$1.45M 1.65%
475,540
– –
GLMD icon
8
Galmed Pharmaceuticals
GLMD
$3.94M
$1.43M 1.63%
1,167
– –
AVXL icon
9
Anavex Life Sciences
AVXL
$222M
$1.13M 1.29%
724,205
– –
EIGR
10
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$764K 0.87%
2,508
– –
SNGX icon
11
Soligenix
SNGX
$5.5M
$721K 0.82%
3,494
– –
EVOK
12
DELISTED
Evoke Pharma
EVOK
$682K 0.78%
1,910
– –
MTEM
13
DELISTED
Molecular Templates, Inc.
MTEM
$460K 0.52%
+7,594
New +$530K
NAGE
14
Niagen Bioscience
NAGE
$256M
$154K 0.18%
45,019
-2,847
-6% -$9.89K
LPCN icon
15
Lipocine
LPCN
$17.1M
$65K 0.07%
2,941
– –
OTRK
16
DELISTED
Ontrak
OTRK
– –
-101
Closed -$102K
VNRX icon
17
VolitionRx Ltd
VNRX
$12M
– –
-16,071
Closed -$916K
NTBL
18
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
– –
-25,622
Closed -$1.49M

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Knoll Capital Management held 18 positions worth $87.9M, down 26% from $118M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Knoll Capital Management's Q4 2018 filing shows 1 new, 1 reduced and 3 closed positions. Its largest new stake was Molecular Templates, Inc.: 7,594 shares worth $460K. The largest sale was Notable Labs, Ltd. Ordinary Shares, an estimated $1.49M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Knoll Capital Management's largest Q4 2018 buy was Molecular Templates, Inc.: 7,594 shares worth $460K.
  • Knoll Capital Management's biggest Q4 2018 reduction was Niagen Bioscience, cutting an estimated $9.89K.
  • Knoll Capital Management fully exited Notable Labs, Ltd. Ordinary Shares in Q4 2018, selling an estimated $1.49M.
  • Knoll Capital Management's ten largest holdings make up 98% of its $87.9M portfolio in Q4 2018.
  • Knoll Capital Management opened 1 new position and closed 3 in Q4 2018.
  • Knoll Capital Management's portfolio value fell 26% quarter-over-quarter to $87.9M.

Based on Knoll Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.